2026 Medical Aid: DHMS vs Other Increases | Moneyweb

South African medical aid members are facing substantial contribution increases for 2026, with Discovery Health Medical Scheme (DHMS) leading the way with increases significantly higher than those proposed by other major schemes. The increases, reported by Moneyweb, are prompting scrutiny of the factors driving up healthcare costs and raising questions about affordability for consumers. This comes amid ongoing concerns about the value offered by medical aid schemes and the sustainability of the current healthcare funding model.

DHMS Increases Outpace the Market

Discovery Health, the largest medical scheme in South Africa, has announced contribution increases averaging 14.9% for 2026. This figure sharply contrasts with the increases proposed by other schemes, which generally fall in the 6% to 8% range. The discrepancy has sparked debate about Discovery’s pricing strategy and its ability to manage costs effectively. While Discovery has not publicly detailed the specific reasons for the higher increases, industry analysts suggest factors such as rising hospital costs, increased utilization of healthcare services, and the impact of the aging population are contributing factors.

The higher increases for DHMS members are particularly notable given the scheme’s already premium positioning in the market. Discovery typically caters to a higher-income demographic, and the substantial increase could lead some members to reconsider their coverage or explore alternative options. The scheme’s market share, currently dominant, could face pressure if members seek more affordable alternatives.

The Broader Landscape of Medical Aid Increases

While DHMS’s increases are the most prominent, all major medical aid schemes are implementing contribution increases for 2026. These increases are driven by a confluence of factors impacting the healthcare industry. Rising healthcare inflation, driven by factors like pharmaceutical costs and advanced medical technologies, is a key contributor. The increasing prevalence of chronic diseases and the growing demand for specialized medical care are putting upward pressure on costs.

Other schemes, such as those offered by Momentum Metropolitan, Liberty, and Sanlam, are proposing increases in the 6% to 8% range. These schemes generally target a broader range of income levels, and their increases reflect a more moderate approach to cost management. However, even these lower increases represent a significant financial burden for many South African households, particularly in the context of a challenging economic environment.

Discovery’s Recent Claims Overpayment Resolution

The announcement of these increases comes shortly after Discovery Health agreed to cover the costs of claims overpayments made to healthcare providers. As reported by Moneyweb, this decision followed pressure from members who had been incorrectly billed for amounts exceeding the scheme’s approved tariffs. The move is expected to cost Discovery a substantial amount, but it aims to restore trust with members and address concerns about billing accuracy.

This resolution, while positive for affected members, adds another layer of complexity to the financial pressures facing the scheme. The cost of covering overpayments will likely contribute to the need for higher contributions in the future. It also highlights the importance of robust claims management processes and accurate billing practices within the healthcare industry.

Impact on Consumers and the Healthcare System

The rising cost of medical aid contributions has significant implications for consumers and the broader healthcare system. For individuals and families, higher contributions reduce disposable income and make it more difficult to afford essential healthcare services. This can lead to delayed or forgone care, potentially resulting in poorer health outcomes.

The affordability crisis in medical aid is also exacerbating inequalities in access to healthcare. Lower-income individuals and families are less likely to be able to afford medical aid coverage, leaving them reliant on the public healthcare system, which is already overburdened and under-resourced. This creates a two-tiered healthcare system, where access to quality care is largely determined by socioeconomic status.

From a systemic perspective, rising medical aid costs are unsustainable in the long run. If contributions continue to increase at a faster rate than inflation, medical aid will become unaffordable for a growing segment of the population, potentially leading to a collapse of the private healthcare system. This would place even greater strain on the public healthcare system, which is ill-equipped to handle a surge in demand.

The Role of the Council for Medical Schemes

The Council for Medical Schemes (CMS) plays a regulatory role in overseeing the medical aid industry in South Africa. The CMS is responsible for ensuring that medical schemes operate in a financially sound manner and that they protect the interests of their members. The Council reviews and approves medical aid contribution increases, but its powers are limited. The CMS can challenge increases that it deems unreasonable, but the decision rests with the scheme’s board of trustees.

The CMS is currently facing calls to exercise greater oversight of medical aid schemes and to implement measures to control costs. Some stakeholders have suggested that the CMS should have the power to directly regulate medical aid contributions or to negotiate prices with healthcare providers. However, such measures could face opposition from the medical aid industry, which argues that they would stifle innovation and reduce competition.

What to Expect Moving Forward

The situation surrounding medical aid contribution increases is likely to remain a key issue in South Africa in the coming months. Members will be closely scrutinizing their schemes’ performance and demanding greater transparency about how their contributions are being used. The CMS will be under pressure to demonstrate its effectiveness in regulating the industry and protecting the interests of consumers.

Further developments to watch include any potential interventions from the government to address the affordability crisis in medical aid. The government could consider measures such as subsidies for low-income individuals or reforms to the healthcare financing system. However, any such interventions would require careful consideration to avoid unintended consequences. The ongoing debate about National Health Insurance (NHI) will also likely influence the future of medical aid in South Africa.

For members of DHMS and other medical aid schemes, the implications of the 2026 contribution increases and to explore all available options. This includes comparing plans, negotiating with their schemes, and seeking financial advice.